Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2024, for Corteva, Inc. and its subsidiary EIDP, Inc. Corteva is a global leader in agricultural science, operating through two reportable segments: Seed and Crop Protection. EIDP, Inc. is a wholly-owned subsidiary of Corteva that continues to file separate reports due to legacy obligations and preferred stock held by third parties. The filing includes unaudited consolidated financial statements and management discussion and analysis.
Key Financial Metrics
| Metric (in millions) | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Net Sales | $2,326 | $2,590 | $12,930 | $13,519 |
| Net Income (Loss) Attributable to Corteva | $(524) | $(321) | $948 | $988 |
| Diluted EPS (Continuing Ops) | $(0.76) | $(0.45) | $1.29 | $1.63 |
| Operating EBITDA (Non-GAAP) | $(100) | $18 | $2,851 | $2,995 |
| Cash from Operating Activities (Continuing) | N/A | N/A | $(1,871) | $(2,574) |
| Total Debt | $5,716 | $5,899 | $5,716 | $5,899 |
| Cash & Cash Equivalents | $2,421 | $2,254 | $2,421 | $2,254 |
Note: Q3 2024 cash flow from operations is not explicitly broken out for the quarter in the summary tables, but the 9-month figure shows a significant improvement in cash usage compared to the prior year.
Material Changes vs. Prior Period
- Revenue Decline: Q3 2024 net sales decreased 10% year-over-year, driven by an 8% price decrease and 5% unfavorable currency impact, partially offset by a 3% volume increase. For the nine months ended September 30, sales declined 4% due to volume and currency headwinds.
- Profitability Pressure: Q3 2024 resulted in a net loss of $524 million compared to a loss of $321 million in Q3 2023. This was primarily due to price declines in Crop Protection, higher Seed commodity costs, and increased R&D investment.
- Restructuring Charges: Restructuring and asset-related charges increased significantly to $32 million in Q3 2024 (vs. $2 million in Q3 2023) and $199 million for the nine months (vs. $95 million). These relate to the "Crop Protection Operations Strategy Restructuring Program."
- Segment Performance:
- Seed: Q3 sales dropped 21% due to reduced corn planted area in Argentina and end-of-season settlements. Operating EBITDA was a loss of $320 million.
- Crop Protection: Q3 sales declined 4% due to pricing pressure in Latin America, though volume increased 11%. Operating EBITDA improved 34% to $246 million, aided by raw material deflation.
Guidance, Outlook, and Risks
Full-Year 2024 Outlook
- Net Sales: Expected to range from $17.0 billion to $17.2 billion (down ~1% at mid-point).
- Operating EBITDA: Expected to range from $3.35 billion to $3.45 billion (up ~1% at mid-point).
- Operating EPS: Expected to range from $2.50 to $2.60 per share (down ~5% at mid-point).
- Free Cash Flow: Expected to range from $1.5 billion to $2.0 billion.
Management Commentary
Management notes that while the Seed business continues to outperform the market and gain share, the Latin America market remains a headwind due to reduced corn acreage. The Crop Protection business is showing resilience with volume stabilization and benefits from raw material deflation, despite a competitive pricing environment.
Risks and Contingencies
- Restructuring: The company expects to record total pre-tax restructuring charges of $650 million to $700 million for the Crop Protection program, with actions expected to be substantially complete by the end of 2026.
- Legal Proceedings: Significant exposure remains regarding legacy PFAS litigation (shared with Chemours and DuPont), the FTC antitrust lawsuit, and Lorsban® personal injury lawsuits. The company has established accruals but notes potential for material additional liabilities.
- Intellectual Property: Ongoing disputes with Bayer regarding Enlist® traits and a recent PTAB decision finding a specific Corteva patent unpatentable (though management believes this does not impact licensing ability).
Investor Verification Checklist
- Restructuring Progress: Verify the timeline and cash impact of the $650M-$700M Crop Protection restructuring program and the associated $180M annualized savings target.
- Argentina Exposure: Assess the impact of reduced corn planted area in Argentina on the Seed segment's volume and the company's ability to manage currency devaluation risks in the region.
- PFAS Liability Cap: Review the cost-sharing arrangement (MOU) with Chemours and DuPont to understand the $2 billion cap on Corteva's share of PFAS liabilities and the status of the Nationwide Water District Settlement.
- Antitrust Litigation: Monitor the status of the FTC lawsuit and related private class actions regarding alleged anticompetitive conduct in the Crop Protection market.
- Capital Allocation: Confirm the execution of the $2 billion share buyback program and the sustainability of the dividend increase to $0.17 per share given the current operating cash flow trends.